Evaluation of Fuling Yunhua Granules and Dihuang Baoyuan Granules in Drug Naive Type 2 Diabetes Patients
Status:
RECRUITING
Trial end date:
2025-01-30
Target enrollment:
Participant gender:
Summary
The goal of this investigator-initiated clinical trial is to investigate the efficacy and safety of sequential therapy of Fuling Yunhua Granules (prescription A) and Dihuang Baoyuan Granule (prescription B) in the treatment of type 2 diabetes patients with poor glycemic control after diet and exercise intervention.
Phase:
PHASE2
Details
Lead Sponsor:
Beijing Supreme Life Pharmaceutical Technology Co., Ltd.